{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:49:50Z","timestamp":1792036190432,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04278-6","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:44:30Z","timestamp":1744476270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intra-ovarian injection of autologous menstrual blood-derived-mesenchymal stromal cells: a safe and promising method to improve pregnancy rate in poor ovarian responders"],"prefix":"10.1186","volume":"16","author":[{"given":"Simin","family":"Zafardoust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Didar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Ghasemi","family":"Ganagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Arefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Arjmandinaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0581-2326","authenticated-orcid":false,"given":"Mina","family":"Fathi-Kazerooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"6","key":"4278_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3390\/ijms21062110","volume":"21","author":"A Abu-Musa","year":"2020","unstructured":"Abu-Musa A, Haahr T, Humaidan P. Novel physiology and definition of poor ovarian response; clinical recommendations. Int J Mol Sci. 2020;21(6):2110.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4278_CR2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"A Ferraretti","year":"2011","unstructured":"Ferraretti A, La Marca A, Fauser B, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u2018poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"9","key":"4278_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/diagnostics10090687","volume":"10","author":"P Giannelou","year":"2020","unstructured":"Giannelou P, Simopoulou M, Grigoriadis S, Makrakis E, Kontogeorgi A, Pantou A, et al. The conundrum of poor ovarian response: from diagnosis to treatment. Diagnostics. 2020;10(9):687.","journal-title":"Diagnostics"},{"key":"4278_CR4","doi-asserted-by":"publisher","first-page":"1215755","DOI":"10.3389\/fendo.2023.1215755","volume":"14","author":"G Lin","year":"2023","unstructured":"Lin G, Zhong X, Li S, Xu L. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1215755.","journal-title":"Front Endocrinol"},{"issue":"1","key":"4278_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12884-023-06112-4","volume":"23","author":"X Duan","year":"2023","unstructured":"Duan X, Li Z, Li M, Ma X. Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study. BMC Pregnancy Childbirth. 2023;23(1):813.","journal-title":"BMC Pregnancy Childbirth"},{"key":"4278_CR6","doi-asserted-by":"publisher","first-page":"1028853","DOI":"10.3389\/fendo.2023.1028853","volume":"14","author":"R-R Wang","year":"2023","unstructured":"Wang R-R, Su M-H, Liu L-Y, Lai Y-Y, Guo X-L, Gan D, et al. Systematic review of acupuncture to improve ovarian function in women with poor ovarian response. Front Endocrinol. 2023;14:1028853.","journal-title":"Front Endocrinol"},{"key":"4278_CR7","doi-asserted-by":"publisher","first-page":"263349412211474","DOI":"10.1177\/26334941221147464","volume":"17","author":"F Di Guardo","year":"2023","unstructured":"Di Guardo F, Pluchino N, Drakopoulos P. Treatment modalities for poor ovarian responders. Ther Adv Reprod Health. 2023;17:26334941221147464.","journal-title":"Ther Adv Reprod Health"},{"issue":"1","key":"4278_CR8","doi-asserted-by":"publisher","first-page":"2292612","DOI":"10.1080\/09537104.2023.2292612","volume":"35","author":"L Wu","year":"2024","unstructured":"Wu L, Su F, Luo P, Dong Q, Ma M, Ye G. The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis. Platelets. 2024;35(1):2292612.","journal-title":"Platelets"},{"issue":"1","key":"4278_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/biology12010108","volume":"12","author":"ZB Mohamed Rasheed","year":"2023","unstructured":"Mohamed Rasheed ZB, Nordin F, Wan Kamarul Zaman WS, Tan Y-F, Abd Aziz NH. Autologous human mesenchymal stem cell-based therapy in infertility: New strategies and future perspectives. Biology. 2023;12(1):108.","journal-title":"Biology"},{"issue":"1","key":"4278_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13287-023-03551-w","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yahaya BH, Pan Y, Liu Y, Lin J. Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency. Stem Cell Res Ther. 2023;14(1):327.","journal-title":"Stem Cell Res Ther"},{"key":"4278_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.reth.2023.11.007","volume":"25","author":"F Kuchakzadeh","year":"2024","unstructured":"Kuchakzadeh F, Ai J, Ebrahimi-Barough S. Tissue engineering and stem cell-based therapeutic strategies for premature ovarian insufficiency. Regen Ther. 2024;25:10\u201323.","journal-title":"Regen Ther"},{"key":"4278_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0461-6","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang Y, Yang T, Li J, Yang X. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017;8:1\u201314.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4278_CR13","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms23116356","volume":"23","author":"VJ Costela-Ruiz","year":"2022","unstructured":"Costela-Ruiz VJ, Melguizo-Rodr\u00edguez L, Bellotti C, Illescas-Montes R, Stanco D, Arciola CR, et al. Different sources of mesenchymal stem cells for tissue regeneration: a guide to identifying the most favorable one in orthopedics and dentistry applications. Int J Mol Sci. 2022;23(11):6356.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4278_CR14","first-page":"9071720","volume":"2019","author":"Y-x Zhao","year":"2019","unstructured":"Zhao Y-x, Chen S-r, Su P-p, Huang F-h, Shi Y-c, Shi Q-y, et al. Using mesenchymal stem cells to treat female infertility: an update on female reproductive diseases. Stem Cells Int. 2019;2019(1):9071720.","journal-title":"Stem Cells Int"},{"key":"4278_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s12015-020-09969-6","volume":"16","author":"S Zafardoust","year":"2020","unstructured":"Zafardoust S, Kazemnejad S, Darzi M, Fathi-Kazerooni M, Rastegari H, Mohammadzadeh A. Improvement of pregnancy rate and live birth rate in poor ovarian responders by intraovarian administration of autologous menstrual blood derived-mesenchymal stromal cells: phase I\/II clinical trial. Stem cell Rev Rep. 2020;16:755\u201363.","journal-title":"Stem cell Rev Rep"},{"issue":"1","key":"4278_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13287-023-03568-1","volume":"14","author":"S Zafardoust","year":"2023","unstructured":"Zafardoust S, Kazemnejad S, Fathi-Kazerooni M, Darzi M, Sadeghi MR, Sadeghi Tabar A, et al. The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response. Stem Cell Res Ther. 2023;14(1):332.","journal-title":"Stem Cell Res Ther"},{"issue":"19","key":"4278_CR17","doi-asserted-by":"publisher","first-page":"14751","DOI":"10.3390\/ijms241914751","volume":"24","author":"CL Chang","year":"2023","unstructured":"Chang CL. Facilitation of ovarian response by mechanical force: latest insight on fertility improvement in women with poor ovarian response or primary ovarian insufficiency. Int J Mol Sci. 2023;24(19):14751.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4278_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jemt.23120","volume":"82","author":"MD Manshadi","year":"2019","unstructured":"Manshadi MD, Navid S, Hoshino Y, Daneshi E, Noory P, Abbasi M. The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure. Microsc Res Tech. 2019;82(6):635\u201342.","journal-title":"Microsc Res Tech"},{"issue":"1","key":"4278_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2020.100477","volume":"21","author":"A Sheikholeslami","year":"2021","unstructured":"Sheikholeslami A, Kalhor N, Sheykhhasan M, Jannatifar R, Sahraei SS. Evaluating differentiation potential of the human menstrual blood-derived stem cells from infertile women into oocyte-like cells. Reprod Biol. 2021;21(1): 100477.","journal-title":"Reprod Biol"},{"issue":"1","key":"4278_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13048-024-01423-2","volume":"17","author":"M \u00c9li\u00e1s","year":"2024","unstructured":"\u00c9li\u00e1s M, K\u00f3nya M, Kekk Z, Turan C, das Virgens IPA, T\u00f3th R, et al. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis. J Ovar Res. 2024;17(1):104.","journal-title":"J Ovar Res."},{"issue":"6","key":"4278_CR21","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00404-024-07442-0","volume":"309","author":"M Vahabi Dastjerdi","year":"2024","unstructured":"Vahabi Dastjerdi M, Sheibani S, Taheri M, Hezarcheshmeh FK, Jahangirian J, Jazayeri M, et al. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis. Arch Gynecol Obstet. 2024;309(6):2323\u201338.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"4278_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1515\/med-2016-0048","volume":"11","author":"V Pavlovic","year":"2016","unstructured":"Pavlovic V, Ciric M, Jovanovic V, Stojanovic P. Platelet rich plasma: a short overview of certain bioactive components. Open Med. 2016;11(1):242\u20137.","journal-title":"Open Med"},{"key":"4278_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejogrb.2022.11.001","volume":"280","author":"R Hosseinisadat","year":"2023","unstructured":"Hosseinisadat R, Nejad AF, Mohammadi F. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: a before and after study. Eur J Obstet Gynecol Reprod Biol. 2023;280:60\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"4278_CR24","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.18632\/aging.203972","volume":"14","author":"Y Cakiroglu","year":"2022","unstructured":"Cakiroglu Y, Yuceturk A, Karaosmanoglu O, Kopuk SY, Korun ZEU, Herlihy N, et al. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Aging. 2022;14(6):2513.","journal-title":"Aging"},{"key":"4278_CR25","doi-asserted-by":"crossref","unstructured":"Safarova S, Akdulum MFC, Guler I, Bozkurt N, Erdem A, Karabacak RO. Does platelet-rich plasma treatment increase in vitro fertilization (IVF) success in the infertile population? Cureus. 2023;15(10).","DOI":"10.7759\/cureus.47239"},{"issue":"9\u201310","key":"4278_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/0963689719859539","volume":"28","author":"K Pantos","year":"2019","unstructured":"Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, et al. A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following platelet-rich plasma treatment. Cell Transpl. 2019;28(9\u201310):1333\u201340.","journal-title":"Cell Transpl"},{"issue":"6","key":"4278_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.10848","volume":"22","author":"I Pacu","year":"2021","unstructured":"Pacu I, Zygouropoulos N, Dimitriu M, Rosu G, Ionescu CA. Use of platelet-rich plasma in the treatment of infertility in poor responders in assisted human reproduction procedures. Exp Ther Med. 2021;22(6):1\u20136.","journal-title":"Exp Ther Med"},{"issue":"1","key":"4278_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43043-024-00180-y","volume":"29","author":"PK Adiga","year":"2024","unstructured":"Adiga PK, Marconi N, N R, Vitthala S. Effect of intra-ovarian injection of platelet-rich plasma on the patients with a poor ovarian response (POR) or premature ovarian insufficiency (POI): a systematic review and meta-analysis. Middle East Fertil Soc J. 2024;29(1):24.","journal-title":"Middle East Fertil Soc J."},{"key":"4278_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-1105-9","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Qu J, Cheng T, Chen X, Xiang C. Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases. Stem Cell Res Ther. 2019;10:1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4278_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/abbs\/gmw090","volume":"48","author":"D Lai","year":"2016","unstructured":"Lai D, Guo Y, Zhang Q, Chen Y, Xiang C. Differentiation of human menstrual blood-derived endometrial mesenchymal stem cells into oocyte-like cells. Acta Biochim Biophys Sin. 2016;48(11):998\u20131005.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"4278_CR31","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3390\/ijms24054254","volume":"24","author":"J Lamceva","year":"2023","unstructured":"Lamceva J, Uljanovs R, Strumfa I. The main theories on the pathogenesis of endometriosis. Int J Mol Sci. 2023;24(5):4254.","journal-title":"Int J Mol Sci"},{"key":"4278_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.879015","volume":"9","author":"PG Signorile","year":"2022","unstructured":"Signorile PG, Viceconte R, Baldi A. New insights in pathogenesis of endometriosis. Front Med. 2022;9: 879015.","journal-title":"Front Med"},{"issue":"1","key":"4278_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/biomedicines11010039","volume":"11","author":"MR Cordeiro","year":"2022","unstructured":"Cordeiro MR, Carvalhos CA, Figueiredo-Dias M. The emerging role of menstrual-blood-derived stem cells in endometriosis. Biomedicines. 2022;11(1):39.","journal-title":"Biomedicines"},{"issue":"10276","key":"4278_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. The Lancet. 2021;397(10276):839\u201352.","journal-title":"The Lancet"},{"key":"4278_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599117","volume":"11","author":"C Agostinis","year":"2021","unstructured":"Agostinis C, Balduit A, Mangogna A, Zito G, Romano F, Ricci G, et al. Immunological basis of the endometriosis: the complement system as a potential therapeutic target. Front Immunol. 2021;11: 599117.","journal-title":"Front Immunol"},{"key":"4278_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114909","volume":"164","author":"M Zhang","year":"2023","unstructured":"Zhang M, Xu T, Tong D, Li S, Yu X, Liu B, et al. Research advances in endometriosis-related signaling pathways: a review. Biomed Pharmacother. 2023;164: 114909.","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"4278_CR37","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.3390\/ijms20153822","volume":"20","author":"RM Marquardt","year":"2019","unstructured":"Marquardt RM, Kim TH, Shin J-H, Jeong J-W. Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis? Int J Mol Sci. 2019;20(15):3822.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4278_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/molehr\/gau044","volume":"20","author":"S Nikoo","year":"2014","unstructured":"Nikoo S, Ebtekar M, Jeddi-Tehrani M, Shervin A, Bozorgmehr M, Vafaei S, et al. Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics. Mol Hum Reprod. 2014;20(9):905\u201318.","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"4278_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5115\/acb.21.169","volume":"55","author":"SS Sahraei","year":"2022","unstructured":"Sahraei SS, Kowsari A, Asl FD, Sheykhhasan M, Naserpoor L, Sheikholeslami A. Evaluating the effect of conditioned medium from endometrial stem cells on endometriosis-derived endometrial stem cells. Anat Cell Biol. 2022;55(1):100\u20138.","journal-title":"Anat Cell Biol"},{"issue":"1","key":"4278_CR40","doi-asserted-by":"publisher","first-page":"7053521","DOI":"10.1155\/2022\/7053521","volume":"2022","author":"SS Sahraei","year":"2022","unstructured":"Sahraei SS, Davoodi Asl F, Kalhor N, Sheykhhasan M, Fazaeli H, Moud SS, et al. A comparative study of gene expression in menstrual blood-derived stromal cells between endometriosis and healthy women. Biomed Res Int. 2022;2022(1):7053521.","journal-title":"Biomed Res Int"},{"issue":"1","key":"4278_CR41","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1038\/s41598-023-35373-4","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, He T, Lin T, Guo Q, Huo C, Roberts SZ, et al. Novel in vivo endometriotic models associated eutopic endometrium by implanting menstrual blood-derived stromal cells from patients with endometriosis. Sci Rep. 2023;13(1):8347.","journal-title":"Sci Rep"},{"key":"4278_CR42","doi-asserted-by":"publisher","DOI":"10.21037\/sci-2022-025","author":"DS Baranovskii","year":"2022","unstructured":"Baranovskii DS, Klabukov ID, Arguchinskaya NV, Yakimova AO, Kisel AA, Yatsenko EM, et al. Adverse events, side effects and complications in mesenchymal stromal cell-based therapies. Stem Cell Investig. 2022. https:\/\/doi.org\/10.21037\/sci-2022-025.","journal-title":"Stem Cell Investig"},{"issue":"2","key":"4278_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.23876\/j.krcp.2017.36.2.200","volume":"36","author":"J-S Kim","year":"2017","unstructured":"Kim J-S, Lee J-H, Kwon O, Cho J-H, Choi J-Y, Park S-H, et al. Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy. Kidney Res Clin Pract. 2017;36(2):200.","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"4278_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13048-024-01448-7","volume":"17","author":"M Gu","year":"2024","unstructured":"Gu M, Wang Y, Yu Y. Ovarian fibrosis: molecular mechanisms and potential therapeutic targets. J Ovar Res. 2024;17(1):139.","journal-title":"J Ovar Res"},{"issue":"5","key":"4278_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1210\/er.2009-0006","volume":"30","author":"F Broekmans","year":"2009","unstructured":"Broekmans F, Soules M, Fauser B. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465\u201393.","journal-title":"Endocr Rev"},{"issue":"1","key":"4278_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13048-023-01151-z","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang X, Wang L, Xiang W. Mechanisms of ovarian aging in women: a review. J Ovar Res. 2023;16(1):67.","journal-title":"J Ovar Res"},{"issue":"9","key":"4278_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ogrm.2022.06.002","volume":"32","author":"N Bhagat","year":"2022","unstructured":"Bhagat N, Gajjar K. Management of ovarian cysts during pregnancy. Obstet Gynaecol Reprod Med. 2022;32(9):205\u201310.","journal-title":"Obstet Gynaecol Reprod Med"},{"issue":"2","key":"4278_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/01443615.2020.1734781","volume":"41","author":"S Senarath","year":"2021","unstructured":"Senarath S, Ades A, Nanayakkara P. Ovarian cysts in pregnancy: a narrative review. J Obstet Gynaecol. 2021;41(2):169\u201375.","journal-title":"J Obstet Gynaecol"},{"key":"4278_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/9781009208802.003","volume-title":"Gynaecology for the obstetrician","author":"MB Zvi","year":"2023","unstructured":"Zvi MB, Thanatsis N, Vashisht A. Ovarian cysts in pregnancy. In: Jha S, Madhuvrata P, editors. Gynaecology for the obstetrician. Cambridge University Press; 2023. p. 1\u201313. https:\/\/doi.org\/10.1017\/9781009208802.003."},{"issue":"3","key":"4278_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.fertnstert.2019.10.018","volume":"113","author":"KA Rodriguez-Wallberg","year":"2020","unstructured":"Rodriguez-Wallberg KA, Lundberg FE, Ekberg S, Johansson AL, Ludvigsson JF, Almqvist C, et al. Mortality from infancy to adolescence in singleton children conceived from assisted reproductive techniques versus naturally conceived singletons in Sweden. Fertil Steril. 2020;113(3):524\u201332.","journal-title":"Fertil Steril"},{"issue":"6","key":"4278_CR51","doi-asserted-by":"publisher","first-page":"e154934","DOI":"10.1001\/jamapediatrics.2015.4934","volume":"170","author":"SL Boulet","year":"2016","unstructured":"Boulet SL, Kirby RS, Reefhuis J, Zhang Y, Sunderam S, Cohen B, et al. Assisted reproductive technology and birth defects among Liveborn infants in Florida, Massachusetts, and Michigan, 2000\u20132010. JAMA Pediatr. 2016;170(6):e154934.","journal-title":"JAMA Pediatr"},{"issue":"49","key":"4278_CR52","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1016\/j.vaccine.2016.03.047","volume":"34","author":"M DeSilva","year":"2016","unstructured":"DeSilva M, Munoz FM, Mcmillan M, Kawai AT, Marshall H, Macartney KK, et al. Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016;34(49):6015.","journal-title":"Vaccine"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T19:03:36Z","timestamp":1744484616000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4278"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04278-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was started after providing complete information to patients and obtaining signed written consent. This clinical study was conducted with the permission of the Ethics Committee for Biomedical Research of the Academic Center for Education, Culture, and Research (ACECR, Tehran, Iran) (IR.ACECR.REC.1397.002, 2018\u201305-06 and IR.ACECR.REC.1399.002, 2020\u201305-31) under the title \"Evaluation of the safety and feasibility of intra-ovarian injection of menstrual blood stem cells in women with poor ovarian responders (POR)\u201d. All procedures observed were under the Declaration of Helsinki, Good Clinical Practice (GCP), and GMP guidelines. Furthermore, this study was registered with the Iranian Clinical Trials Registry (IRCT20180619040147N2) and ClinicalTrials.gov (NCT05703308). The cell manufacturing was performed by STERCO (Tehran, Iran) in a GMP clean room authorized by Iran Food and Drug Administration authorities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to participate"}},{"value":"Not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interests"}}],"article-number":"171"}}